DrazCanna, Inc.

Equities

DZCA

US8257842000

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 07:59:30 20/06/2024 pm IST			5-day change	1st Jan Change
0.0361 ^USD	-24.79%		0.00%	-90.37%

2023	EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million.	CI
2023	Drazcanna, Inc. Announces CEO Changes	CI

Sibling Group Holdings, Inc. Appoints Glenn A. Delk as General Counsel and Interim Chief Executive Officer

November 18, 2013 at 07:30 pm IST

Sibling Group Holdings, Inc. announced that it has appointed Glenn A. Delk as its general counsel. He was a founder of NEWCO4EDUCATION, LLC, which was acquired by Sibling in 2010, and remains a shareholder. Mr. Delk will also serve as the interim Chief Executive Officer.

Latest news about DrazCanna, Inc.

EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million.	30/11	CI
Drazcanna, Inc. Announces CEO Changes	02/11	CI
Drazcanna, Inc. Announces CFO Changes	02/11	CI
Drazcanna, Inc. Announces Executive Changes	02/11	CI
Sibling Group Holdings, Inc. Announces Resignation of David W. Saba as Chief Operating Officer	31/16/31	CI
Global Personalized Academics Announces Expansion Plans	23/15/23	CI
Sibling Group Holdings Seeks Acquisitions	09/15/09	CI
Sibling Group Holdings, Inc. Announces Executive Appointments	06/15/06	CI
DrazCanna, Inc. Auditor Raises 'Going Concern' Doubt	23/15/23	CI
Sibling Group Holdings, Inc. Announces New Appointments, Effective July 20, 2015	20/15/20	CI
Sibling Group Holdings, Inc. Terminates Richard Marshall as Chief Development Officer	02/15/02	CI
Sibling Group Holdings, Inc. Announces Management Changes	19/15/19	CI
Sibling Group Holdings, Inc. Announces Demise of Maurine Findley, Chairman of Board of Directors	08/15/08	CI
Sibling Group Holdings, Inc. Announces Formation of Strategic Partnership and Completion of $3.75 Million Funding from Shenzhen City Qianhai Xinshi Education Management Co., Ltd	06/15/06	CI
Sibling Group Holdings, Inc. announced that it has received $0.1 million in funding.	27/15/27	CI
Sibling Group Holdings, Inc. Announces Executive Changes	30/15/30	CI
Sibling Group Holdings, Inc. completed the acquisition of the assets of Urban Planet Media & Entertainment Corp.	30/15/30	CI
Sibling Group Holdings, Inc. announced that it has received $0.25 million in funding from FireRock Capital, Inc.	05/14/05	CI
Sibling Group Holdings, Inc. announced that it expects to receive $0.25 million in funding from FireRock Capital, Inc.	01/14/01	CI
Sibling Group Holdings, Inc. cancelled the acquisition of the assets and operations EDEVATE.	18/14/18	CI
Sibling Group Holdings, Inc. signed a non-binding letter of intent to acquire the assets of Urban Planet Media & Entertainment Corp.	30/14/30	CI
Sibling Group Holdings, Inc. Appoints Jed Friedrichsen to Academic Advisory Board	16/14/16	CI
Sibling Group Holdings, Inc. Announces Management Changes	25/14/25	CI
Sibling Group Mulls Acquisitions	25/14/25	CI
Sibling Group Holdings, Inc. completed the acquisition of assets and operations of Blendedschools.net.	30/14/30	CI

Chart DrazCanna, Inc.

Duration

Period

More charts

Company Profile

DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
DRAZCANNA, INC.	-90.37%	347K
MODERNA, INC.	+19.41%	45.51B
LONZA GROUP AG	+38.65%	39.36B
IQVIA HOLDINGS INC.	-8.62%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+26.95%	30.74B
CELLTRION, INC.	-13.50%	26.03B
ICON PUBLIC LIMITED COMPANY	+10.74%	25.92B
UNITED THERAPEUTICS CORPORATION	+44.87%	14.13B
MEDPACE HOLDINGS, INC.	+34.36%	12.73B
BIO-TECHNE CORPORATION	-7.14%	11.29B

Other Biotechnology & Medical Research